David James Harrison
CIK: 0002123693
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NCNA
NuCana plc
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Harrison David James
Harrison David James (SEC CIK 0002123693) files insider reports with the SEC as Head of Translational Medicine of NuCana plc (NCNA).
Signal8 holds 1 ownership filing by Harrison David James, a Form 3, filed on Mar 24, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Harrison David James's filings is in EDINBURGH.
Other insiders filing for NuCana plc (NCNA)
- Levy Elliott M., Director
- Bloss Jeffrey D., Chief Medical Officer
- Bruce Theresa Margaret Ms, Chief Operating Officer
- Mellish Martin C.B., Director
- Webster Ian Alexander
- Kay Andrew Martin, Director